Related references
Note: Only part of the references are listed.Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer
Carol A. Lange et al.
ENDOCRINE-RELATED CANCER (2011)
The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma
Deniz M. Ozata et al.
ENDOCRINE-RELATED CANCER (2011)
miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells
Ming Liu et al.
FEBS LETTERS (2011)
miR-15 and miR-16 Are Direct Transcriptional Targets of E2F1 that Limit E2F-Induced Proliferation by Targeting Cyclin E
Matan Ofir et al.
MOLECULAR CANCER RESEARCH (2011)
Efficiently identifying genome-wide changes with next-generation sequencing data
Weichun Huang et al.
NUCLEIC ACIDS RESEARCH (2011)
MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8
L. Fang et al.
ONCOGENE (2011)
Nuclear Outsourcing of RNA Interference Components to Human Mitochondria
Simonetta Bandiera et al.
PLOS ONE (2011)
An Integrated Bioinformatics Approach Identifies Elevated Cyclin E2 Expression and E2F Activity as Distinct Features of Tamoxifen Resistant Breast Tumors
Lei Huang et al.
PLOS ONE (2011)
Improving Validation Practices in Omics Research
John P. A. Ioannidis et al.
SCIENCE (2011)
Cannibalism, cell survival, and endocrine resistance in breast cancer
Robert Clarke
BREAST CANCER RESEARCH (2011)
Eukaryotic snoRNAs: A paradigm for gene expression flexibility
Giorgio Dieci et al.
GENOMICS (2009)
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
Liang Shi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Epidermal Growth Factor Receptor Responsive miR-125a Represses Mesenchymal Morphology in Ovarian Cancer Cells
Karen D. Cowden Dahl et al.
NEOPLASIA (2009)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
CYP2D6 and tamoxifen: DNA matters in breast cancer
Janelle M. Hoskins et al.
NATURE REVIEWS CANCER (2009)
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
Sherene Loi et al.
BMC GENOMICS (2008)
Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
S. E. Elsheikh et al.
BRITISH JOURNAL OF CANCER (2008)
Free circulating mRNA in plasma from breast cancer patients and clinical outcome
Vanesa Garcia et al.
CANCER LETTERS (2008)
Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor
Selma Masri et al.
CANCER RESEARCH (2008)
MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
Tyler E. Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Clinical importance of estrogen receptor-β evaluation in breast cancer patients treated with adjuvant tamoxifen therapy
Naoko Honma et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A Human snoRNA with MicroRNA-Like Functions
Christine Ender et al.
MOLECULAR CELL (2008)
Expression of hepatocyte nuclear factor 4α in primary ovarian mucinous tumors
Mika Sugai et al.
PATHOLOGY INTERNATIONAL (2008)
Gene-environment interaction in yeast gene expression
Erin N. Smith et al.
PLOS BIOLOGY (2008)
Oligonucleotide microarray analysis of estrogen receptor α-positive postmenopausal breast carcinomas:: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen
S. Toziu-Kara et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2007)
Role of human hepatocyte nuclear factor 4 alpha in the expression of drug-metabolizing enzymes and transporters in human Hepatocytes assessed by use of small interfering RNA
Yoshiteru Kamiyama et al.
DRUG METABOLISM AND PHARMACOKINETICS (2007)
Mapping determinants of gene expression plasticity by genetical genomics in C-elegans
Yang Li et al.
PLOS GENETICS (2006)
Cyclin D1 is necessary for tamoxifen-induced cell cycle progression in human breast cancer cells
Robin L. Kilker et al.
CANCER RESEARCH (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity
RJ Santen et al.
ENDOCRINE-RELATED CANCER (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Molecular changes in tamoxifen-resistant breast cancer: Relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase
MC Gutierrez et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling
MPHM Jansen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells
RL Kilker et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
XJ Ma et al.
CANCER CELL (2004)
Mechanisms of the deleterious effects of tamoxifen on mitochondrial respiration rate and phosphorylation efficiency
CMP Cardoso et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2001)
Molecular and pharmacological aspects of antiestrogen resistance
R Clarke et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2001)
Tamoxifen resistance in breast cancer - Elucidating mechanisms
LCJ Dorssers et al.
DRUGS (2001)
Share Paper
